709 related articles for article (PubMed ID: 11807556)
21. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.
Northcott PA; Shih DJ; Remke M; Cho YJ; Kool M; Hawkins C; Eberhart CG; Dubuc A; Guettouche T; Cardentey Y; Bouffet E; Pomeroy SL; Marra M; Malkin D; Rutka JT; Korshunov A; Pfister S; Taylor MD
Acta Neuropathol; 2012 Apr; 123(4):615-26. PubMed ID: 22057785
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
[TBL] [Abstract][Full Text] [Related]
23. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
24. Are molecular subgroups of medulloblastomas really prognostic?
Frappaz D; Faure-Conter C; Meyronet D; Levard-Bonneville A; Beuriat PA; Sunyach MP; Barritault M
Curr Opin Neurol; 2018 Dec; 31(6):747-751. PubMed ID: 30300240
[TBL] [Abstract][Full Text] [Related]
25. Medulloblastomas, CNS embryonal tumors, and cerebellar mutism syndrome: advances in care and future directions.
Patel N; Keating G; Solanki GA; Syed HR; Keating RF
Childs Nerv Syst; 2023 Oct; 39(10):2633-2647. PubMed ID: 37632526
[TBL] [Abstract][Full Text] [Related]
26. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
Sharma T; Schwalbe EC; Williamson D; Sill M; Hovestadt V; Mynarek M; Rutkowski S; Robinson GW; Gajjar A; Cavalli F; Ramaswamy V; Taylor MD; Lindsey JC; Hill RM; Jäger N; Korshunov A; Hicks D; Bailey S; Kool M; Chavez L; Northcott PA; Pfister SM; Clifford SC
Acta Neuropathol; 2019 Aug; 138(2):309-326. PubMed ID: 31076851
[TBL] [Abstract][Full Text] [Related]
27. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
28. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
Frühwald MC; O'Dorisio MS; Rush LJ; Reiter JL; Smiraglia DJ; Wenger G; Costello JF; White PS; Krahe R; Brodeur GM; Plass C
J Med Genet; 2000 Jul; 37(7):501-9. PubMed ID: 10882752
[TBL] [Abstract][Full Text] [Related]
29. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
30. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
[TBL] [Abstract][Full Text] [Related]
31. Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC; Mahoney EL; Pomeroy SL
Neurotherapeutics; 2017 Apr; 14(2):265-273. PubMed ID: 28386677
[TBL] [Abstract][Full Text] [Related]
32. Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup.
da Silva LS; Mançano BM; de Paula FE; Dos Reis MB; de Almeida GC; Matsushita M; Junior CA; Evangelista AF; Saggioro F; Serafini LN; Stavale JN; Malheiros SMF; Lima M; Hajj GNM; de Lima MA; Taylor MD; Leal LF; Reis RM
J Mol Diagn; 2020 Jul; 22(7):957-966. PubMed ID: 32380172
[TBL] [Abstract][Full Text] [Related]
33. Subtypes of medulloblastoma have distinct developmental origins.
Gibson P; Tong Y; Robinson G; Thompson MC; Currle DS; Eden C; Kranenburg TA; Hogg T; Poppleton H; Martin J; Finkelstein D; Pounds S; Weiss A; Patay Z; Scoggins M; Ogg R; Pei Y; Yang ZJ; Brun S; Lee Y; Zindy F; Lindsey JC; Taketo MM; Boop FA; Sanford RA; Gajjar A; Clifford SC; Roussel MF; McKinnon PJ; Gutmann DH; Ellison DW; Wechsler-Reya R; Gilbertson RJ
Nature; 2010 Dec; 468(7327):1095-9. PubMed ID: 21150899
[TBL] [Abstract][Full Text] [Related]
34. Childhood cerebellar tumours mirror conserved fetal transcriptional programs.
Vladoiu MC; El-Hamamy I; Donovan LK; Farooq H; Holgado BL; Sundaravadanam Y; Ramaswamy V; Hendrikse LD; Kumar S; Mack SC; Lee JJY; Fong V; Juraschka K; Przelicki D; Michealraj A; Skowron P; Luu B; Suzuki H; Morrissy AS; Cavalli FMG; Garzia L; Daniels C; Wu X; Qazi MA; Singh SK; Chan JA; Marra MA; Malkin D; Dirks P; Heisler L; Pugh T; Ng K; Notta F; Thompson EM; Kleinman CL; Joyner AL; Jabado N; Stein L; Taylor MD
Nature; 2019 Aug; 572(7767):67-73. PubMed ID: 31043743
[TBL] [Abstract][Full Text] [Related]
35. Genetic and expression profiles of cerebellar liponeurocytomas.
Horstmann S; Perry A; Reifenberger G; Giangaspero F; Huang H; Hara A; Masuoka J; Rainov NG; Bergmann M; Heppner FL; Brandner S; Chimelli L; Montagna N; Jackson T; Davis DG; Markesbery WR; Ellison DW; Weller RO; Taddei GL; Conti R; Del Bigio MR; González-Cámpora R; Radhakrishnan VV; Söylemezoglu F; Uro-Coste E; Qian J; Kleihues P; Ohgaki H
Brain Pathol; 2004 Jul; 14(3):281-9. PubMed ID: 15446583
[TBL] [Abstract][Full Text] [Related]
36. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas.
Fernandez-Teijeiro A; Betensky RA; Sturla LM; Kim JY; Tamayo P; Pomeroy SL
J Clin Oncol; 2004 Mar; 22(6):994-8. PubMed ID: 14970184
[TBL] [Abstract][Full Text] [Related]
37. [Subtypes of medulloblastomas: distinct cellular origins].
Bourdeaut F; Pouponnot C; Ayrault O
Med Sci (Paris); 2012 Oct; 28(10):805-9. PubMed ID: 23067406
[No Abstract] [Full Text] [Related]
38. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
[TBL] [Abstract][Full Text] [Related]
39. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
[TBL] [Abstract][Full Text] [Related]
40. Embryonal brain tumor with unknown primary lesion and massive cerebrospinal fluid dissemination: A case report.
Tanaka H; Yamamoto D; Ikeda M; Morikawa M; Ueda K; Tanaka K; Sasayama T; Kohmura E
J Clin Neurosci; 2018 Aug; 54():125-128. PubMed ID: 29843922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
